Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19

LY3127804（一种抗血管生成素-2抗体）在肺炎住院患者中治疗的疗效和安全性：一项随机、双盲、安慰剂对照临床试验，研究对象为疑似或确诊COVID-19患者。